Lopimune Tablet (60), a prescription drug, is manufactured in various forms such as Tablet. Lopimune Tablet (60) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Lopimune Tablet (60) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Lopimune Tablet (60) are Headache. Apart from the aforementioned side effects, Lopimune Tablet (60) can also lead to other problems, which have been listed below. Usually, these side effects of Lopimune Tablet (60) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Lopimune Tablet (60)'s effect during pregnancy is Moderate and Moderate while nursing. In addition, Lopimune Tablet (60)'s effects on the liver, heart and kidney are discussed below in the Lopimune Tablet (60) related warnings section.
Lopimune Tablet (60) is contraindicated in people with pre-existing medical conditions like Liver Disease, Hemophilia as it can result in adverse effects. Some other conditions that can be affected by Lopimune Tablet (60) are listed in the contraindications section below.
Additionally, Lopimune Tablet (60) may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Lopimune Tablet (60), it is important to know that it is not safe while driving, and is not habit-forming.
Lopimune Tablet (60) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Lopimune Tablet (60) safe for pregnant women?
Lopimune may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Lopimune again without your doctor's advice.
Is the use of Lopimune Tablet (60) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Lopimune. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Lopimune Tablet (60) on the Kidneys?
Using Lopimune does not have any harmful effects on kidneys.
What is the effect of Lopimune Tablet (60) on the Liver?
Side effects of Lopimune rarely affect the liver.
What is the effect of Lopimune Tablet (60) on the Heart?
Side effects of Lopimune rarely affect the heart.
Lopimune Tablet (60) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Lopimune Tablet (60) unless your doctor advises you to do so -
Is this Lopimune Tablet (60) habit forming or addictive?
Lopimune Tablet (60) does not cause addiction.
Interaction between Food and Lopimune Tablet (60)
When consumed with certain foods, Lopimune Tablet (60) may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Lopimune Tablet (60)
Taking Lopimune Tablet (60) with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvir (ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 810
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 939-941
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Kaletra (lopinavir and ritonavir)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 811